Maladies Transmissibles

Filtres

Résultats

Rapport Annuel PNLT.Cameroun.2023

Date de publication: 2023
Auteurs: prise_en_charge_des_casmaladies_transmissiblesrapport_dactivitesfr
Thumbnail"

Seroprevalence of SARS-CoV-2 (COVID-19) among Health Care Workers in Three Health Facilities of Yaoundé, Center Region of Cameroon.2021

Date de publication: 2021-12-13
Auteurs: Philippe Salomon Nguwoh, Akenji Blaise Mboringong, Joseph Fokam, et al.prise_en_charge_des_casmaladies_transmissiblesarticles_scientifiquesfr

Introduction: Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first appeared in December 2019 in Wuhan, China and has subsequently become a worldwide pandemic. During the pandemic, health care workers (HCWs) were very exposed to COVID-19 infected patients. The aim of this study was to determine seroprevalence of SARS-CoV-2 (COVID-19) among HCWs in three health facilities of Yaounde. Methods: A cross-sectional study involving 368 HCWs was conducted from January 18th to February 13th, 2021, in three health facilities located in city of Yaounde. Data of study participants were collected by face-to-face interviews using standard questionnaire.…

Guide technique TB multirésistante.Cameroun.2025

Date de publication: 2025
Auteurs: prise_en_charge_des_casmaladies_transmissiblesguidesfr
Thumbnail"

Diagnostic performance evaluation of the Abbott Bioline™ HIV-Syphilis Duo rapid test at the national public health laboratory, Yaounde-Cameroon.2026

Date de publication: 2026-01-05
Auteurs: Philippe Salomon Nguwoh, Christian Taheu Ngounouh, René Ghislain Essomba, et al.prise_en_charge_des_casmaladies_transmissiblesarticles_scientifiquesfr

Background The Bioline™ HIV/Syphilis Duo rapid diagnostic test (RDT) is the first World Health Organization (WHO) prequalified Duo RDT for the simultaneous detection of human immunodeficiency virus (HIV) and Treponema pallidum antibodies in human blood samples. Several studies have shown the satisfactory diagnostic performance of this test among vulnerable populations such as pregnant women. However, the diagnostic performance of this Duo test is scarce in the general population in Cameroon. The present study aimed to assess the diagnostic performance of the Abbot Bioline™ HIV/Syphilis Duo RDT in Cameroon. Methods A laboratory based cross-sectional and comparative study was conducted from January,…

Guide technique TB sensible.Cameroun.2019

Date de publication: 2019
Auteurs: MINSANTEprise_en_charge_des_casmaladies_transmissiblesguidesfr

Final report on Stigmatization of TB Patients and Health Care Providers.Cameroon.2021

Date de publication: 2022
Auteurs: Programme National deLlutte contre la Tuberculoseprise_en_charge_des_casmaladies_transmissiblesarticles_scientifiquesen

Décision portant réorganisation du GTCPNLT.Cameroun.2006.

Date de publication: 2006-10-05
Auteurs: MINSANTEgouvernance_pilotage_systeme_de_santemaladies_transmissiblestextes_reglementaires_legislatifsfr
Thumbnail"

Diagnostic performance of the Hightop Rapid Diagnostic Test for the detection of anti-Treponema pallidum antibodies in Cameroon: a laboratory-based crosssectional and comparative study.2025.Pdf

Date de publication: 2025-08-11
Auteurs: Christian Taheu Ngounouh, Philippe Salomon Nguwoh, Joseph Fokam, et al.prise_en_charge_des_casmaladies_transmissiblesarticles_scientifiques

Objective The study was conducted to assess the diagnostic performance of the Hightop Syphilis Rapid Diagnostic Test (RDT) in comparison with the ELISA test used as a reference method. Design A laboratory-based cross-sectional and comparative study was conducted to assess the diagnostic performance of the Hightop Syphilis RDT. Setting Blood samples obtained from adult participants in eight health facilities were analysed at the National Public Health Laboratory (NPHL), Ministry of Public Health, Yaounde, Cameroon. Participants From 29 April to 25 August 2023, 583 adult participants of both sexes (aged ≥21 years), including both syphilis positive and syphilis negative, were recruited…

Décision modifiant et complétant organisation de lutte contre la tuberculose.Cameroun.2016

Date de publication: 2016-06-08
Auteurs: MINSANTEgouvernance_pilotage_systeme_de_santemaladies_transmissiblestextes_reglementaires_legislatifsfr

Sociodemographic and obstetric determinants of HIV infection among pregnant women in Cameroon: a contribution toward the elimination of vertical transmission in low- and middle- income countries.Cameroun.2016

Date de publication: 2026-01-23
Auteurs: Justin NdiéJean Pierre Yves Awono Noah, Francis Ateba Ndongo, Joseph Fokam, Alice Ketchaji, Rogacien Kana Dongmo, Jean Dieu Anoubissi, Christian Noël Bayiha, Richard Tchapda, Tatiana Avang Nkoa Palisson, Martial Gaël Bonyohe, Caroline Teh Monteh, Njamnshi Yembe Wepnyu, Félicité Naah Tabala, Gildas Nguemkam, Hernandez Lélé Siaka, Carelle Djofang Yepndo, Audrey Raïssa Djomo Nzaddi, Daniel Offrande Mabongo, Maurice Rocher Mbella, Marie Micheline Dongmo, Ngo Issouck, Nelly Monkam, Leopoldine Madjo Oumbe, Clifford Moluh, Paul Tjek, Vittorio Colizzi, Carlo-Federico Perno, Giulia Cappelli, Nicaise Ndembi, David Kob, Gregory-Edie Halle Ekane, Basile Keugoung, Alexis Ndjolo, Serge Clotaire Billong, Céline Nkenfoumaladies_transmissiblesarticles_scientifiquesen

Background: The risk of HIV transmission during pregnancy remains a concern in Cameroon. Recent estimates suggest a national HIV prevalence of approximately 4.5%, increasing the likelihood of vertical transmission. Objective: To estimate HIV seroprevalence and identify sociodemographic and obstetric determinants of HIV infection among pregnant women attending antenatal care in Cameroon. Methods: A cross-sectional study was conducted from September 2022 to June 2023 among pregnant women aged 15 years and above in 324 health facilities across eight regions. Consecutive voluntary sampling was used until the site-specific sample size was reached. Facilities were purposively selected based on monthly ANC attendance >30.…

Retour en haut